Explore FHI 360

Practice Area

Research

There is an art to improving lives. And it’s in our science.

Expertise

FHI 360's clinical trials have evaluated the safety, effectiveness and acceptability of virtually every contraceptive method. For example, we are currently supporting the identification and early testing of innovative approaches to a longer-acting...

Published research

Women's perspectives on contraceptive-induced amenorrhea in Burkina Faso and Uganda

Published research

Effect of excessive gestational weight gain on pregnancy outcome: A case study of tertiary hospitals in Benue State, Nigeria

Project

Innovate FP: Expanding Options, Enhancing Method Choice

Innovate FP is a contraceptive research project to expand desirable, affordable, quality contraceptive options to better meet the needs of women.

Published research

Sexual function after voluntary medical male circumcision for human immunodeficiency virus prevention: Results from a programmatic delivery setting in Botswana

Published research

Brief report: Phase IIa safety study of a vaginal ring containing dapivirine in adolescent young women

Project

Research for Scalable Solutions (R4S)

The Research for Scalable Solutions (R4S) project, conducts implementation science research to improve the efficiency, cost-effectiveness and equity of family planning programs in Africa and Asia.

News

Award will continue work to advance contraceptive technology innovation

The Bill & Melinda Gates Foundation granted a four-year award to expand and strengthen ongoing development and evaluation of new contraceptives, under the Contraceptive Technology Innovation (CTI) Initiative.

Published research

Contraceptive use and the risk of sexually transmitted infection: Systematic review and current perspectives

The authors reviewed the evidence on the association between contraceptive use and sexually transmitted infections and bacterial vaginosis published over the last 10 years. Few data are available from prospective studies. But, new evidence suggests a significantly increased risk of herpes simplex virus type 2 infection among depot medroxyprogesterone acetate (DMPA) users. DMPA users should be counseled on this possible increased risk, and new research is warranted to better understand the association.

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Research

Reproductive health research

Women's perspectives on contraceptive-induced amenorrhea in Burkina Faso and Uganda

Effect of excessive gestational weight gain on pregnancy outcome: A case study of tertiary hospitals in Benue State, Nigeria

Innovate FP: Expanding Options, Enhancing Method Choice

Sexual function after voluntary medical male circumcision for human immunodeficiency virus prevention: Results from a programmatic delivery setting in Botswana

Brief report: Phase IIa safety study of a vaginal ring containing dapivirine in adolescent young women

Research for Scalable Solutions (R4S)

Award will continue work to advance contraceptive technology innovation

Contraceptive use and the risk of sexually transmitted infection: Systematic review and current perspectives

You are here

Search FHI 360

Practice Areas

Services

Content Types

Expertise Areas

Countries

Article Types

Resource Types

Search within these results

79 Results Found

Contraceptive use and the risk of sexually transmitted infection: Systematic review and current perspectives